Loan & DebtMar 29, 2026, 07:51 PM
Novartis Issues $11.75 Billion in Debt Securities
AI Summary
Novartis AG, through its Novartis Capital Corporation, issued $11.75 billion in aggregate principal amount of debt securities, including floating rate notes and fixed-rate notes maturing between 2029 and 2056. The proceeds are likely for general corporate purposes, and the issuance provides Novartis with additional financial flexibility.
Key Highlights
- Issued $500 million in Floating Rate Notes due 2029.
- Issued $1.25 billion in 4.100% Notes due 2029.
- Issued $1.75 billion in 4.400% Notes due 2031.
- Issued $2.00 billion in 4.600% Notes due 2033.
- Issued $2.25 billion in 4.900% Notes due 2036.
- Issued $1.00 billion in 5.600% Notes due 2046.
- Issued $2.25 billion in 5.700% Notes due 2056.
Price Impact
More from NVS